Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Cytarabine
Oral Cladribine
Locations
1
United States
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States
Start Date
December 1, 2027
Primary Completion Date
June 30, 2028
Completion Date
June 30, 2030
Last Updated
March 4, 2026
NCT07500441
NCT05756777
NCT05768932
NCT07451912
NCT06660368
NCT05143996
Lead Sponsor
M.D. Anderson Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions